HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
50 hedge funds and large institutions have $279M invested in Harpoon Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
50
Holders Change
+8
Holders Change %
+19.05%
% of All Funds
0.99%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
13
Increased
22
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
MB
1
MPM BioImpact
Boston,
Massachusetts
|
$57.7M |
2 |
AG
2
Artal Group
Luxembourg
|
$12.6M |
3 |
3
BlackRock
New York
|
$6.76M |
4 |
SCM
4
Soleus Capital Management
Greenwich,
Connecticut
|
$1.82M |
5 |
5
Renaissance Technologies
New York
|
$1.66M |